SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,930,553 | -40.4% | 9,240,887 | +5.7% | 0.74% | -30.1% |
| Q2 2023 | $58,563,943 | +2.9% | 8,740,887 | 0.0% | 1.06% | -5.0% |
| Q1 2023 | $56,903,174 | -23.7% | 8,740,887 | 0.0% | 1.12% | -21.7% |
| Q4 2022 | $74,559,766 | +61.6% | 8,740,887 | 0.0% | 1.43% | +66.4% |
| Q3 2022 | $46,152,000 | +24.5% | 8,740,887 | 0.0% | 0.86% | +27.5% |
| Q2 2022 | $37,061,000 | +20.8% | 8,740,887 | 0.0% | 0.67% | +35.2% |
| Q1 2022 | $30,681,000 | -47.3% | 8,740,887 | 0.0% | 0.50% | -33.6% |
| Q4 2021 | $58,214,000 | -33.3% | 8,740,887 | 0.0% | 0.75% | -22.0% |
| Q3 2021 | $87,234,000 | -67.7% | 8,740,887 | 0.0% | 0.96% | -64.9% |
| Q2 2021 | $270,006,000 | -29.2% | 8,740,887 | 0.0% | 2.73% | -23.4% |
| Q1 2021 | $381,365,000 | -5.8% | 8,740,887 | 0.0% | 3.57% | +0.6% |
| Q4 2020 | $405,053,000 | – | 8,740,887 | – | 3.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 1,910,029 | $12,721,000 | 3.35% |
| Orbimed Advisors | 8,740,887 | $58,214,000 | 0.75% |
| Nantahala Capital Management | 1,006,462 | $6,703,000 | 0.24% |
| EcoR1 Capital, LLC | 1,060,010 | $7,060,000 | 0.22% |
| Prosight Management, LP | 53,815 | $358,000 | 0.21% |
| RA Capital Management | 1,742,186 | $11,603,000 | 0.20% |
| Endurant Capital Management LP | 84,295 | $561,000 | 0.14% |
| HighVista Strategies LLC | 22,434 | $149,000 | 0.12% |
| XTX Topco Ltd | 18,816 | $125,000 | 0.07% |
| WASATCH ADVISORS LP | 1,773,690 | $11,813,000 | 0.05% |